Article Topic
September 2, 2025: U.S. compounding restrictions have stemmed a flood of compounded semaglutide and tirzepatide
Chinese companies that supplied U.S. compounders have turned to making generic semaglutide for markets where Novo Nordisk’s main patent is expiring in 2026.
[...]Affidavits, USA v Rebecca Fadanelli, October 2024
United States District Court District of Massachusetts USA v Rebecca Fadanelli Affidavits Filed October 2024 Read the documents: 1 | 2
[...]Plea Agreement, USA v Facial Expressions, June 2025
United States District Court Eastern District of Kentucky Southern Division, London USA v Facial Expressions Plea Agreement Filed June 10, 2025 Read the document.
[...]Information, USA v Facial Expressions June 2025
United States District Court Eastern District of Kentucky Southern Division, London USA v Facial Expressions Information Filed June 9, 2025 Read the document.
[...]Prescription Drug Affordability Board Activity, July 2025
Prescription Drug Affordability Board Activity, July 2025 Activities Summary Colorado: Colorado’s PDAB met on July 11, 2025 for a rulemaking hearing to set an upper payment limit for Enbrel, during which they heard substantial public comment. They will continue this process at their next meeting on August 22. Maryland: At its July 28 meeting, Maryland’s…
[...]August 18, 2025: PSM, ADAP ask New York’s Board of Pharmacy to act in alleged fake medicine case
On August 7, the Partnership for Safe Medicines and ADAP Advocacy Association filed a complaint asking the New York State Board of Pharmacy to take regulatory action against a pharmacy that allegedly sold counterfeit HIV medicine to a Queens, New York patient.
[...]Tell us about your alternative funding program
Used an alternative funding program? Tell us your story The Partnership for Safe Medicines is researching alternative funding programs. If you are a patient or an administrator, we’d like to confidentially interview you to understand how you have encountered these programs, how they work, and what your experience was. If you’re ready to interview, or…
[...]August 4, 2025: Pennsylvania pharmacy owner indicted and 14 licenses revoked in Ohio
The Pennsylvania Attorney General filed charges against a pharmacy owner and the Ohio Board of Pharmacy revoked licenses to protect patients.
[...]July 28, 2025: Suspicious shipments of API continue to be sent to buyers in the U.S.
The newest Fishy Freight report continued to find suspect API shipped into the U.S. while a report from the United Nations’ Office of Drug Crime highlighted the dangers of contaminated and counterfeit medicines made with diethylene glycol and ethylene glycol.
[...]Prescription Drug Freight Fraud Report, July 2025
What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…
[...]